Mark Pruzanski
Direttore/Membro del Consiglio presso EQUILLIUM, INC.
Patrimonio netto: 35 699 $ in data 31/05/2024
Provenienza dei contatti di primo grado di Mark Pruzanski
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
McGill University
222
| College/University | Other Consumer Services | 222 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.
220
| Non-Profit Organization | Miscellaneous Commercial Services | 220 |
McMaster University
72
| College/University | Other Consumer Services | 72 |
| Public Company | Pharmaceuticals: Major | 58 | |
| Public Company | Biotechnology | 18 | |
eGenesis, Inc.
 eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA.
11
| Holding Company | Miscellaneous Commercial Services | 11 |
Versanis Bio, Inc.
 Versanis Bio, Inc. BiotechnologyHealth Technology Part of Eli Lilly & Co., Versanis Bio, Inc. is a clinical-stage biopharmaceutical company. The company is based in New York, NY. The company was founded by Lloyd Klickstein. Mark E. Pruzanski has been the CEO of the company since 2021. Versanis Bio was acquired by Eli Lilly & Co. on August 14, 2023 for $1,925 million.
7
| Subsidiary | Biotechnology | 7 |
Foundation for the Defense of Democracies
7
| Private Company | 7 | |
Intercept Pharma Europe Ltd.
 Intercept Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Intercept Pharma Europe Ltd. is a subsidiary of Intercept Pharmaceuticals, Inc. that researches, develops, and sells pharmaceutical products. The company is based in Bristol, UK.
3
| Subsidiary | Miscellaneous Commercial Services | 3 |
Johns Hopkins University School of Advanced International
2
| College/University | Other Consumer Services | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Mark Pruzanski tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal | |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | President Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | General Counsel Corporate Officer/Principal Sales & Marketing | |
| GILEAD SCIENCES, INC. | Biotechnology | Director/Board Member Sales & Marketing Corporate Officer/Principal | |
| IMMUNOGEN, INC. | Biotechnology | Chief Executive Officer Director/Board Member Chief Executive Officer | |
| IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member Sales & Marketing General Counsel | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Operating Officer Director/Board Member Chief Operating Officer Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal President Public Communications Contact | |
| VANDA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin Graduate Degree Graduate Degree Undergraduate Degree Doctorate Degree | |
| AFFYMAX, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| University of Oxford | College/University | Undergraduate Degree Undergraduate Degree | |
| MACROGENICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Founder | |
| BIOCON LIMITED | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| Louisiana State University | College/University | Undergraduate Degree Doctorate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Tufts University | College/University | Undergraduate Degree Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal President Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Director/Board Member | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
The Biotechnology Institute
 The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services The Biotechnology Institute is a non-profit organization, which engages in designing and managing programs about biotechnology research. Its programs include BioGENEius Challenges, leadership awards, and Adopt-A-School. The company was founded in 1998 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| RELYPSA INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
CropLife International
 CropLife International Advertising/Marketing ServicesCommercial Services CropLife International operates as a marketing agency for agricultural innovations in crop protection and plant biotechnology. The private company is based in Brussels, Belgium. | Advertising/Marketing Services | Director/Board Member Director/Board Member Director/Board Member | |
Genextra SpA
 Genextra SpA Investment ManagersFinance Genextra SpA (Genextra) is a venture capital firm founded in 2004 by Franceso Micheli and Saverio Minucci. The firm is headquartered in Milan, Italy. | Investment Managers | Corporate Officer/Principal Chief Executive Officer | |
EryDel SpA
 EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Medical Specialties | Chairman Director/Board Member | |
Tethis SpA
 Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | Biotechnology | Chairman Chief Executive Officer | |
| TRAVERE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| VOYAGER THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Corporate Secretary | |
Petra Pharma Corp.
 Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Petra Pharma Corp. operates as a drug development company that develops novel small molecules for the treatment of cancer and metabolic diseases. The company was founded by Lewis Clayton Cantley and Nathanael S. Gray in 2016 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Hangzhou Qihan Biotech Co., Ltd.
 Hangzhou Qihan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Hangzhou Qihan Biotech Co., Ltd. is a biotech company that applies genome-editing technology to develop novel cell therapies and organs for transplantation. The company is based in Hangzhou, China. The Chinese company's mission is to create immunologically privileged allogeneic cells and xenogeneic organs for use as therapies to treat cancer, organ failure, and other complex medical conditions. Qihan Biotech has raised two rounds of financing and is advancing its cell therapy programs into IND enabling investigations. It was founded in 2017 by Luhan Yang and George McDonald Church, with Luhan Yang serving as the CEO since then. | Medical/Nursing Services | Director/Board Member Chairman | |
Intercept Pharma UK & Ireland Ltd.
 Intercept Pharma UK & Ireland Ltd. Medical DistributorsDistribution Services Founded in 2015, Intercept Pharma UK & Ireland Ltd. is a pharmaceutical wholesaler. Part of Intercept Pharmaceuticals, Inc., the company is based in Bristol, UK. | Medical Distributors | Director/Board Member Director/Board Member | |
Intercept Pharma Deutschland GmbH
 Intercept Pharma Deutschland GmbH Medical DistributorsDistribution Services Part of Intercept Pharmaceuticals, Inc., Intercept Pharma Deutschland GmbH is a German company focused on building a healthier tomorrow for patients with progressive non-viral liver diseases. The company is based in Munich, Germany. The CEOs are Rocco Venezia, Michael Gemellaro, Willem Wouter Van Weperen. The company was founded in 2015. | Medical Distributors | Chief Executive Officer Chief Executive Officer |
Statistiche
Distribuzione geografica
| Stati Uniti | 40 |
| Regno Unito | 4 |
| Italia | 4 |
| India | 2 |
| Belgio | 2 |
Settori
| Health Technology | 32 |
| Consumer Services | 9 |
| Commercial Services | 6 |
| Distribution Services | 3 |
| Finance | 2 |
Posizioni
| Director/Board Member | 801 |
| Corporate Officer/Principal | 263 |
| Independent Dir/Board Member | 209 |
| Chairman | 174 |
| Chief Executive Officer | 140 |
Contatti più connessi
| Insiders | |
|---|---|
| Paul Sekhri | 62 |
| Steven Gillis | 58 |
| Daniel Bradbury | 45 |
| Jonathan Leff | 45 |
| Jonathan Silverstein | 42 |
| Robert More | 42 |
| Steven Paul | 39 |
| John Maraganore | 38 |
| Jon Fyrwald | 35 |
| Ted Love | 31 |
| David Willetts | 29 |
| Steven Holtzman | 28 |
| David Pyott | 27 |
| David Stack | 27 |
| James Sapirstein | 26 |
- Borsa valori
- Insiders
- Mark Pruzanski
- Connessioni Società
